| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| Omnicell, Inc. |
| 1101 East Meadow Drive, Palo Alto, CA 94303 * (650) 251-6100 |
| Business Description | The company provides a comprehensive, buyer-focused, supply chain management solution that addresses the limitations of the traditional healthcare supply chain. |
| Offering Information Company has | |||
| Trading As | OMCL (NASNTL) | Industry | High-Tech (SIC 3571) |
| Type of Stock Offered | Common Shares | Filing Date | 3/14/2001 |
| Domestic Shares Offered | 6,000,000 | Offer Date | 8/6/2001 |
| Foreign Shares Offered | 0 | Filing Range | $7.00 - $9.00 |
| Company Shares | 6,000,000 | Offer Price | $7.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $0.490 |
| Gross Proceeds | $42,000,000 | Selling | $0.290 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 20,680,000 | Employees | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| U.S. Bancorp Piper Jaffray | Lead Manager | (612) 342-6220 |
| CIBC World Markets | Co-manager | (212) 667-7400 |
| SG Cowen | Co-manager | (212) 495-6000 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | - - Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1996 | 12/31/1997 | 12/31/1998 | 12/31/1999 | 12/31/2000 | ||
| Revenues | 21.554 | 36.073 | 48.212 | 53.381 | 64.210 | - | - |
| Income from Oper. | -11.154 | -10.941 | -0.211 | -25.826 | -21.296 | - | - |
| Net Income | -10.460 | -10.189 | 0.643 | -27.742 | -22.552 | - | - |
| E.P.S | -10.390 | -8.930 | 0.480 | -18.860 | -13.230 | - | - |
| Revenue Growth (%) | 67.36 | 33.65 | 10.72 | 20.286 | - | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | 1.33 | - | - | - | - |
| Cash Flow - Oper. | -19.11 | - | - | ||||
| Cash Flow - Inv. | 1.36 | - | - | ||||
| Cash Flow - Fin. | - | - | - | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 12/31/2000 | Financial Ratios | ||||
| Total Assets | 43.91 | Current Assets | 36.15 | Current Ratio | 0.67 |
| Total Liab. | 72.98 | Current Liab. | 53.65 | Debt Ratio | 166.22% |
| Total Equity | -29.08 | Working Cap. | -17.50 | Debt to Equity Ratio | - |
| Cash | 9.68 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to repay debt owed to Baxter Healthcare, to expand sales, marketing and customer support activities, to continue the development and marketing of the Omnicell commerce Network and for working capital and other general corporate purposes, including potential acquisitions. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Cooley Godward Castro Huddleson & Tatum |
| Bank's Law Firm | Preston Gates & Ellis |
| Registrar/Transfer Agent | EquiServe |
| Auditor | Ernst & Young |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Entities affiliated with Sutter Hill Ventures | 20.80 | |
| Medicus Venture Partners | 8.80 | |
| ABS Capital Partners III, L.P. | 8.60 | |
| Nassau Capital Partners, L.P. | 7.50 | |
| Entities affiliated with Oak Investment Partners | 5.90 | |
| Note: represents ownership of 5% or more prior to the offering. | ||